The American Association for Cancer Research’s annual meeting is the first of the large oncology conferences for the year, and its focus on science includes a broad range of agents from preclinical to late-stage development. The ONCrg team of experts is optimally positioned to interpret new clinical findings and place them within the context of drug development for each tumor type, as well as interpret preclinical data in the context of Emerging IO.
Drawing on expertise honed year-round by our dedicated disease area specialists, ONCrg prepares detailed agendas identifying high-impact presentations. During and immediately after the conference, our team of experts sifts through the presentations, paying close attention to details while also placing them into the context of the clinical landscape at large. ONCrg’s unique conference reports provide clients with clear, digestible top-line trends backed by granular developments. Clients also have access to our analysts post-conference to gather additional commentary and Q&A to guide strategic decision making.
Ask our Conference Lead Analyst about ONCrg Conference coverage.